Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)
Brazil
· Delayed Price · Currency is BRL 7.87
+0.09 (1.16%)
May 12, 2025, 5:07 PM GMT-3
BVMF:PFRM3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 10,613 | 10,154 | 8,662 | 7,816 | 6,413 | 5,481 | Upgrade
|
| Revenue Growth (YoY) | 19.40% | 17.22% | 10.82% | 21.88% | 17.00% | 14.16% | Upgrade
|
| Cost of Revenue | 9,023 | 8,631 | 7,370 | 6,671 | 5,506 | 4,718 | Upgrade
|
| Gross Profit | 1,590 | 1,523 | 1,292 | 1,146 | 907.57 | 763.57 | Upgrade
|
| Selling, General & Admin | 1,282 | 1,225 | 1,046 | 916.83 | 668.28 | 567 | Upgrade
|
| Other Operating Expenses | 3.69 | -1.79 | -15.5 | -14.27 | -9.64 | -23.31 | Upgrade
|
| Operating Expenses | 1,286 | 1,223 | 1,031 | 902.56 | 771.32 | 635.29 | Upgrade
|
| Operating Income | 304.11 | 299.65 | 261.12 | 242.95 | 136.25 | 128.28 | Upgrade
|
| Interest Expense | -155.9 | -149.39 | -161.9 | -149.2 | -76.16 | -67.22 | Upgrade
|
| Interest & Investment Income | 8.3 | 8.3 | 10.95 | 8.68 | 4.9 | 4.26 | Upgrade
|
| Earnings From Equity Investments | 0.01 | 0.04 | 0.01 | -0.01 | 5.98 | 4.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -28.33 | -30.74 | -28.59 | -23.46 | -10.71 | -24.53 | Upgrade
|
| EBT Excluding Unusual Items | 128.19 | 127.86 | 81.59 | 78.97 | 60.26 | 44.89 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -11.52 | -11.74 | Upgrade
|
| Pretax Income | 128.19 | 127.86 | 81.59 | 78.97 | 48.75 | 33.15 | Upgrade
|
| Income Tax Expense | -4.31 | 5.05 | 3.74 | -6.07 | -30.37 | -28.65 | Upgrade
|
| Earnings From Continuing Operations | 132.5 | 122.81 | 77.86 | 85.04 | 79.11 | 61.8 | Upgrade
|
| Minority Interest in Earnings | -7.95 | -8.23 | -7.46 | -4.17 | -0.92 | -9.46 | Upgrade
|
| Net Income | 124.54 | 114.58 | 70.4 | 80.87 | 78.19 | 52.33 | Upgrade
|
| Net Income to Common | 124.54 | 114.58 | 70.4 | 80.87 | 78.19 | 52.33 | Upgrade
|
| Net Income Growth | 61.52% | 62.76% | -12.96% | 3.43% | 49.41% | 336.92% | Upgrade
|
| Shares Outstanding (Basic) | 123 | 123 | 123 | 123 | 123 | 123 | Upgrade
|
| Shares Outstanding (Diluted) | 123 | 123 | 123 | 123 | 123 | 123 | Upgrade
|
| Shares Change (YoY) | 0.44% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 1.01 | 0.93 | 0.57 | 0.66 | 0.64 | 0.43 | Upgrade
|
| EPS (Diluted) | 1.01 | 0.93 | 0.57 | 0.66 | 0.64 | 0.43 | Upgrade
|
| EPS Growth | 60.74% | 62.72% | -12.98% | 3.43% | 49.41% | 336.92% | Upgrade
|
| Free Cash Flow | 286.57 | 394.56 | 193.37 | 66.37 | 39.04 | 3.3 | Upgrade
|
| Free Cash Flow Per Share | 2.33 | 3.22 | 1.58 | 0.54 | 0.32 | 0.03 | Upgrade
|
| Dividend Per Share | 0.575 | 0.575 | 0.386 | 0.173 | 0.271 | - | Upgrade
|
| Dividend Growth | 49.05% | 49.05% | 122.58% | -35.94% | - | - | Upgrade
|
| Gross Margin | 14.98% | 15.00% | 14.92% | 14.66% | 14.15% | 13.93% | Upgrade
|
| Operating Margin | 2.86% | 2.95% | 3.02% | 3.11% | 2.13% | 2.34% | Upgrade
|
| Profit Margin | 1.17% | 1.13% | 0.81% | 1.03% | 1.22% | 0.95% | Upgrade
|
| Free Cash Flow Margin | 2.70% | 3.89% | 2.23% | 0.85% | 0.61% | 0.06% | Upgrade
|
| EBITDA | 350.21 | 342.15 | 295.65 | 273.34 | 162.72 | 149.91 | Upgrade
|
| EBITDA Margin | 3.30% | 3.37% | 3.41% | 3.50% | 2.54% | 2.73% | Upgrade
|
| D&A For EBITDA | 46.1 | 42.5 | 34.52 | 30.38 | 26.47 | 21.64 | Upgrade
|
| EBIT | 304.11 | 299.65 | 261.12 | 242.95 | 136.25 | 128.28 | Upgrade
|
| EBIT Margin | 2.86% | 2.95% | 3.02% | 3.11% | 2.13% | 2.34% | Upgrade
|
| Effective Tax Rate | - | 3.95% | 4.58% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.